Abstract
Aortokoronar shuntlash operatsiyasi (AKSH) dunyoda eng ko‘p amalga oshiriladigan va qimmat operatsiyalardan biri bo‘lib, nostabil stenokardiya simptomlaridan mukammal darajada xalos bo‘lishni ta'minlaydi va bemorlarning umrini uzaytirishga hissa qo‘shadi. Biroq, koronar xavf omillarining kamayishi, antitrombotik dorilarni qo‘llashga qaramay, aortokoronar shuntlash operatsiyasidan keyin takroriy nostabil stenokardiya rivojlanish holatlari uchrab turibdi. Aortokoronar shuntlash operatsiyasi o‘tqazilgan qon tomirlarda arterial bosim va rivojlanib boruvchi arteriyalar aterosklerozi tomir o‘tkazuvchanligi ikkilamchi buzilishi holatlarini keltirib chiqarishi tez tez uchramoqda.
References
,,Percutaneous coronary interventions in patients with prior coronary artery bypass surgery: changes in patient characteristics and outcome during two decades
Unterberg C ,Buchwald A, Wiegand V ,Kreuzer H.,,Coronary angioplasty inpatients with previous coronary artery bypass grafting.’’ Angiology.1992;43:653±660.
Gade S. V. Miguel, MD, PhD,1 Alexandre G. Sousa, MD,2 Gilmara S. Silva, MSc,3 Flávia C. Colósimo, PhD,3 and Noedir A. G. Stolf, PhD4
,,Does Prior Percutaneous Coronary Intervention Influence the Outcomes of Coronary Artery Bypass Surgery?’’ 2020 Jan-Feb; 35(1): 1–8. doi: 10.21470/1678-9741-2019-0234
Mandeep Singh ,,Twenty-Five–Year Trends in In-Hospital and Long-Term Outcome After Percutaneous Coronary Intervention’’ https://www.ahajournals.org/doi/10.1161/circulationaha.106.632679
3. Verghese Mathew MD.,, Percutaneous coronary interventions in patients with prior coronary artery bypass surgery: changes in patient characteristics and outcome during two decades’’ The American Journal of Medicine
Volume 108, Issue 2, February 2000, Pages 127-135
DeepakL.Bhatt,MD,EricJ.Topol,MD,,Percutaneous Coronary Intervention for Patients with Prior Bypass Surgery :Therapy in Evolution’’ February2000 THE AMERICAN JOURNAL OF MEDICINE
Ru Liu MD,, For patients with prior coronary artery bypass grafting and recurrent myocardial ischemia, percutaneous coronary intervention on bypass graft or native coronary artery?—A 5-year follow-up cohort study’’ : 585-587 15 June 2023 https://doi.org/10.1002/clc.24021
2. John S Douglas Jr ,, Percutaneous coronary intervention in patients with prior coronary bypass surgery in 2012’’ Interventional Cardiology (2012) Volume 4, Issue 1
Tursunova, L. D., & Jabbarov, O. O. (2023). Cardiorenal Syndrome in Patients with Chronic Kidney Disease and Diabetes Mellitus. American Journal of Pediatric Medicine and Health Sciences (2993-2149), 1(9), 332-339.
ТУРСУНОВА, Л., & ЖАББАРОВ, О. (2023). СУРУНКАЛИ БУЙРАК КАСАЛЛИГИ ВА СУРУНКАЛИ ЮРАК ЕТИШМОВЧИЛИГИДА ГИПОТЕНЗИВ ДАВОНИНГ САМАРАСИ.
Турсунова, Л. Д., & Жаббаров, О. О. (2023). ЧАСТОТА СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТИ У БОЛЬНЫХ С ДИАБЕТИЧЕСКОЙ НЕФРОПАТИЕЙ САХАРНОГО ДИАБЕТА 2 ТИПА (Doctoral dissertation, Российский национальный конгресс кардиологов 2023).
ТУРСУНОВА, Л., & ЖАББАРОВ, О. (2023). РОЛЬ НАТРИЙУРЕТИЧЕСКИХ ПЕПТИДОВ В ЗАВИСИМОСТИ ОТ СТАДИИ ХРОНИЧЕСКОЙ БОЛЕЗНИ ПОЧЕК.
ТУРСУНОВА, Л., & ЖАББАРОВ, О. (2023). ПРИМЕНЕНИЯ САКУБИТРИЛ/ВАЛСАРТАНА У БОЛЬНЫХ С СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТЬЮ С НИЗКОЙ ФРАКЦИЕЙ ВЫБРОСА.
This work is licensed under a Creative Commons Attribution 4.0 International License.